Kaiserslautern

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Heart failure2 trials
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• AstraZeneca4 trials

Running trials

• Recruiting

  A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia

  NCT07619118· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany

  NCT06336330· AstraZeneca· Source

• Recruiting

  PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

  NCT05573893· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting

Closed trials

• Recruiting

  Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  NCT06307652· Phase 3· AstraZeneca· Source